As a leader in global health, the safety of our patients, customers and employees is our top priority. In these challenging times, many of HONEUR’s current and prospective data partner institutions are on the frontline of the battle with COVID-19. Their work in caring for those affected is of paramount importance.
Our HONEUR country representatives want to respect the urgent priorities facing hospitals right now, so we will work with participating and potentially interested sites only as they deem appropriate.
Within Janssen, we are continuing to progress HONEUR, as it remains a key strategic initiative in enabling real-time, real-world evidence studies using data from federated networks. We look forward to returning to full speed in due course.
We would also like to extend our gratitude and thanks to all healthcare professionals for their exceptional efforts in caring for patients at this time.
The HONEUR Team
To create a secure, collaborative platform that enables participants across Europe to liberate the transformational potential of Real World Data.
We want to help create a future where patients with haematological malignancies across Europe receive the best possible treatment because the power of Real World Data is being maximised.
ITEM CODE: CP-73766 | DATE OF PREPARATION: FEBRUARY 2019